ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,036 | -18.8% | 68,080 | 0.0% | 0.16% | -18.3% |
| Q2 2023 | $456,817 | -24.0% | 68,080 | 0.0% | 0.19% | -28.5% |
| Q1 2023 | $601,146 | +15.6% | 68,080 | 0.0% | 0.27% | +3.9% |
| Q4 2022 | $520,131 | +7.3% | 68,080 | 0.0% | 0.26% | +4.5% |
| Q3 2022 | $484,730 | -12.0% | 68,080 | 0.0% | 0.25% | -10.9% |
| Q2 2022 | $550,767 | -41.7% | 68,080 | 0.0% | 0.28% | -45.2% |
| Q1 2022 | $944,950 | -50.5% | 68,080 | 0.0% | 0.50% | -69.3% |
| Q4 2021 | $1,910,325 | -57.8% | 68,080 | -48.9% | 1.64% | -63.4% |
| Q3 2021 | $4,531,887 | -16.8% | 133,330 | 0.0% | 4.48% | -21.8% |
| Q2 2021 | $5,447,864 | – | 133,330 | – | 5.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |